MICROSATELLITE STABLE (MSS) COLON CANCER

Clinical trials for MICROSATELLITE STABLE (MSS) COLON CANCER explained in plain language.

Never miss a new study

Get alerted when new MICROSATELLITE STABLE (MSS) COLON CANCER trials appear

Sign up with your email to follow new studies for MICROSATELLITE STABLE (MSS) COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hopeful new combo tested for Tough-to-Treat cancers

Disease control Completed

This study tested whether combining two drugs—copanlisib and nivolumab—could help control advanced cancers that had stopped responding to standard treatments. It focused on a specific type of colorectal cancer (called MSS) that is often resistant to immunotherapy. The main goals …

Matched conditions: MICROSATELLITE STABLE (MSS) COLON CANCER

Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

MICROSATELLITE STABLE (MSS) COLON CANCER

Get alerted when new MICROSATELLITE STABLE (MSS) COLON CANCER trials appear

Hopeful new combo tested for Tough-to-Treat cancers